Omni Bio Pharmaceutical, Inc. filed its 10-K on Jun 16, 2014 for the period ending Mar 31, 2014. In this report its auditor, Hein & Associates LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +66.67% | +233.33% |
2016 | Omni Bio Pharmaceutical, Inc. cancelled the transaction announced on March 16, 2015 | CI |
2015 | Omni Bio Pharmaceutical, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 50.06K | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.07% | 22.39B | |
-10.79% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- OMBP Stock
- News Omni Bio Pharmaceutical, Inc.
- Omni Bio Pharmaceutical, Inc. Auditor Raises 'Going Concern' Doubt